Review of clinical studies on clobazam
- PMID: 35197
- PMCID: PMC1429541
- DOI: 10.1111/j.1365-2125.1979.tb04684.x
Review of clinical studies on clobazam
Abstract
1 Clobazam was compared with placebo and diazepam in 45 double-blind studies. 2 Clobazam dosage ranged from 5 mg daily (paediatric patients) to 120 mg daily (psychiatric in-patients). Usual daily dosage in out-patient therapy ranged from 20-30 mg clobazam. 3 Treatment duration varied from a few days up to 3.5 years. The usual duration of treatment was 2-4 weeks. 4 Clobazam was shown to be an efficacious and well tolerated anxiolytic agent in various neurotic and psychosomatic disorders. 5 Dosages showing distinct anxiolytic effects in out-patient therapy did not impair psychomotor performance.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
